After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Takeda Pharmaceutical Co ADR is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Takeda Pharmaceutical Co ADR is $47.14B. A total of 2.23 million shares were traded on the day, compared to an average of 2.10M shares.
In the most recent transaction, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares of TAK for 8.10 per share on Jan 24 ’24. After the transaction, the 10% Owner now owns 3,755,583 company shares.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Takeda Pharmaceutical Co ADR pays an annual dividend of $0.61, resulting in a dividend yield of 4.09%, and it has a price to earnings (P/E) ratio of 48.95.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TAK has a high of $16.39 and a low of $12.57.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TAK’s latest balance sheet shows that the firm has $875.00B in Cash & Short Term Investments as of fiscal 2022. There were $4.35T in debt and $2.15T in liabilities at the time. Its Book Value Per Share was $15.45, while its Total Shareholder’s Equity was $5.68T.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TAK is Buy with a score of 4.50.
